283 related articles for article (PubMed ID: 31851436)
1. Real-World Effectiveness of Ramelteon and Suvorexant for Delirium Prevention in 948 Patients With Delirium Risk Factors.
Hatta K; Kishi Y; Wada K; Takeuchi T; Hashimoto N; Suda K; Taira T; Tsuchida K; Ohmori T; Akizuki N; Nishio Y; Nakanishi Y; Usui C; Kurata A; Horikawa N; Eguchi H; Ito S; Muto H; Nakamura H; Uchimura N
J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31851436
[TBL] [Abstract][Full Text] [Related]
2. Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients.
Kawada K; Ohta T; Tanaka K; Miyamura M; Tanaka S
J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):142-148. PubMed ID: 30322756
[TBL] [Abstract][Full Text] [Related]
3. Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease: A Retrospective Cohort Study.
Henmi R; Nakamura T; Mashimoto M; Takase F; Ozone M
J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):369-377. PubMed ID: 38820374
[TBL] [Abstract][Full Text] [Related]
4. Suvorexant with or without ramelteon to prevent delirium: a systematic review and meta-analysis.
Tian Y; Qin Z; Han Y
Psychogeriatrics; 2022 Mar; 22(2):259-268. PubMed ID: 34881812
[TBL] [Abstract][Full Text] [Related]
5. Melatonin, Ramelteon, Suvorexant, and Dexmedetomidine to Promote Sleep and Prevent Delirium in Critically Ill Patients: A Narrative Review With Practical Applications.
Fontaine GV; Der Nigoghossian C; Hamilton LA
Crit Care Nurs Q; 2020; 43(2):232-250. PubMed ID: 32084065
[TBL] [Abstract][Full Text] [Related]
6. Suvorexant for the prevention of delirium: A meta-analysis.
Xu S; Cui Y; Shen J; Wang P
Medicine (Baltimore); 2020 Jul; 99(30):e21043. PubMed ID: 32791676
[TBL] [Abstract][Full Text] [Related]
7. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial.
Hatta K; Kishi Y; Wada K; Takeuchi T; Odawara T; Usui C; Nakamura H;
JAMA Psychiatry; 2014 Apr; 71(4):397-403. PubMed ID: 24554232
[TBL] [Abstract][Full Text] [Related]
8. The role of suvorexant in the prevention of delirium during acute hospitalization: A systematic review.
Adams AD; Pepin MJ; Brown JN
J Crit Care; 2020 Oct; 59():1-5. PubMed ID: 32480359
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of Suvorexant for Complicated Delirium in Cancer Patients Who Experience Sleep Disturbance during Hospitalization].
Kessoku T; Kusakabe A; Matsuura T; Honda Y; Yoshimi A; Goto A; Yoshida H; Sukegawa A; Hata C; Saito Y; Miyashita Y; Yashiro R; Komori T; Arai S; Nakajima A; Ichikawa Y
Gan To Kagaku Ryoho; 2018 Mar; 45(Suppl 1):92-94. PubMed ID: 29650886
[TBL] [Abstract][Full Text] [Related]
10. [Association Suvorexant and Ramelteon Use with the Risk of Falling: A Retrospective Case-control Study].
Ishigo T; Takada R; Kondo F; Ibe Y; Nakano K; Tateishi R; Fujii S; Katano S; Kitagawa M; Kimyo T; Nakata H; Hashimoto A; Miyamoto A
Yakugaku Zasshi; 2020; 140(8):1041-1049. PubMed ID: 32741862
[TBL] [Abstract][Full Text] [Related]
11. Preventive Effects of Suvorexant on Delirium: A Randomized Placebo-Controlled Trial.
Hatta K; Kishi Y; Wada K; Takeuchi T; Ito S; Kurata A; Murakami K; Sugita M; Usui C; Nakamura H;
J Clin Psychiatry; 2017; 78(8):e970-e979. PubMed ID: 28767209
[TBL] [Abstract][Full Text] [Related]
12. Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study.
Ishibashi Y; Nishitani R; Shimura A; Takeuchi A; Touko M; Kato T; Chiba S; Ashidate K; Ishiwata N; Ichijo T; Sasabe M
PLoS One; 2020; 15(9):e0238723. PubMed ID: 32916693
[TBL] [Abstract][Full Text] [Related]
13. Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant.
Booka E; Tsubosa Y; Matsumoto T; Takeuchi M; Kitani T; Nagaoka M; Imai A; Kamijo T; Iida Y; Shimada A; Takebayashi K; Niihara M; Mori K; Onitsuka T; Takeuchi H; Kitagawa Y
Esophagus; 2017; 14(3):229-234. PubMed ID: 28725169
[TBL] [Abstract][Full Text] [Related]
14. Effects of suvorexant on sleep apnea in patients with heart failure: A protocol of crossover pilot trial.
Shitara J; Kasai T; Akihiro S; Yatsu S; Matsumoto H; Suda S; Ogita M; Yanagisawa N; Fujibayashi K; Nojiri S; Nishizaki Y; Ono N; Suwa S; Daida H
J Cardiol; 2019 Jul; 74(1):90-94. PubMed ID: 30737183
[TBL] [Abstract][Full Text] [Related]
15. Effects of Ramelteon on the Prevention of Postoperative Delirium in Older Patients Undergoing Orthopedic Surgery: The RECOVER Randomized Controlled Trial.
Oh ES; Leoutsakos JM; Rosenberg PB; Pletnikova AM; Khanuja HS; Sterling RS; Oni JK; Sieber FE; Fedarko NS; Akhlaghi N; Neufeld KJ
Am J Geriatr Psychiatry; 2021 Jan; 29(1):90-100. PubMed ID: 32532654
[TBL] [Abstract][Full Text] [Related]
16. Real-World Preventive Effects of Suvorexant in Intensive Care Delirium: A Retrospective Cohort Study.
Izuhara M; Izuhara HK; Tsuchie K; Araki T; Ito T; Sato K; Miura S; Otsuki K; Nagahama M; Hayashida M; Hashioka S; Wake R; Kimura T; Tsumoto S; Saito Y; Inagaki M
J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33027560
[TBL] [Abstract][Full Text] [Related]
17. Suvorexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study.
Kishi T; Sakuma K; Okuya M; Ninomiya K; Oya K; Kubo M; Matsui Y; Nomura I; Okuyama Y; Matsunaga S; Iwata N
Neuropsychopharmacol Rep; 2019 Sep; 39(3):252-255. PubMed ID: 31283862
[TBL] [Abstract][Full Text] [Related]
18. Suvorexant is associated with a low incidence of delirium in critically ill patients: a retrospective cohort study.
Masuyama T; Sanui M; Yoshida N; Iizuka Y; Ogi K; Yagihashi S; Nagatomo K; Sasabuchi Y; Lefor AK
Psychogeriatrics; 2018 May; 18(3):209-215. PubMed ID: 29423967
[TBL] [Abstract][Full Text] [Related]
19. Association of Hypnotic Drug Use with Fall Incidents in Hospitalized Elderly Patients: A Case-Crossover Study.
Torii H; Ando M; Tomita H; Kobaru T; Tanaka M; Fujimoto K; Shimizu R; Ikesue H; Okusada S; Hashida T; Kume N
Biol Pharm Bull; 2020; 43(6):925-931. PubMed ID: 32475914
[TBL] [Abstract][Full Text] [Related]
20. Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials.
Herring WJ; Connor KM; Snyder E; Snavely DB; Zhang Y; Hutzelmann J; Matzura-Wolfe D; Benca RM; Krystal AD; Walsh JK; Lines C; Roth T; Michelson D
J Clin Sleep Med; 2016 Sep; 12(9):1215-25. PubMed ID: 27397664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
